Andere Sprachen Avricore Health Inc.

Aktien

A2N8S1

CA0545211090

AVCR

Markt geschlossen - Toronto S.E. Andere Börsenplätze 15:35:58 05.07.2024			% 5 Tage	% 1. Jan.
0,16 ^CAD	-3,03 %		-3,03 %	-5,88 %

03.06.	Avricore Health erzielt im ersten Quartal einen Gewinn	MT
31.05.	Avricore Health Inc. meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Avricore Health Swings to a First-Quarter Profit	03.06.
AVRICORE HEALTH CORPORATE UPDATE – COMPANY ACHIEVES PROFITABILITY	03.06.
AVRICORE HEALTH CORPORATE UPDATE – COMPANY ACHIEVES PROFITABILITY	03.06.
Avricore Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	31.05.
Avricore Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	30.04.
Avricore Health Corporate Update and Audited Results for 2023	30.04.
Avricore Health Inc. - HealthTab Signs Agreement for More Rexall Pharmacy Locations	05.04.
Avricore's HealthTab Signs Agreement for More Rexall Pharmacy Locations	04.04.
HealthTab™ Signs Agreement for More Rexall® Pharmacy Locations	04.04.
Avricore Health Provides Update on Q3	30.11.
Avricore Health Corporate Update – Company Demonstrates Strong Growth	30.11.
Avricore Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29.11.
Avricore Health Inc. - HealthTab Supports Patient Testing in the First Rexall Pharmacy Walk-In Clinic	20.09.23
HealthTab™ Supports Patient Testing in the First Rexall® Pharmacy Walk-In Clinic	15.09.23
Avricore Health Inc. Expands Its Innovative Point-Of-Care Chronic and Infectious Disease Screening and Health- Data Management Platform, Healthtab	15.09.23
Avricore Health Corporate Update – Mid-Year Review Demonstrates Company on Right Track	30.08.23
Avricore Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29.08.23
Avricore's HealthTab Selected for Feasibility Study for Testing in Community Pharmacies in United Kingdom	09.08.23
Avricore Health Inc. - HealthTab Signs Reseller Agreement with Abbott to Support UK Expansion	09.08.23
Avricore Health Up Nearly 14% After Reporting Reseller Pact Between HealthTab, Abbott Rapid Dx UK & Ireland	08.08.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Avricore Health Inc.

Aktien

A2N8S1

CA0545211090

AVCR

Andere Sprachen

Filter